A patient-reported questionnaire may eliminate the need for an ophthalmic exam before belantamab mafodotin dosing in TI NDMM

Whole body-MRI and fluorine 18 fluorodeoxyglucose PET/CT shows promising diagnostic accuracy in multiple myeloma patients

Ponatinib is better than imatinib for frontline treatment of newly diagnosed Ph+ acute lymphoblastic leukaemia

Best practice in HRRm testing in patients with metastatic prostate cancer

ASCO 2024: Highlights and analysis

Clinical behaviour of breast cancer in young BRCA carriers and prognostic impact of the timing of genetic testing

Looking at real world evidence on PSA testing in prostate cancer

Bone disease evaluation of newly diagnosed MM with combined use of 18F-FDG PET/CT and whole-body diffusion weighted MRI

Grand Rounds: Improving quality of patient-centred care

A combined PET-MRI scan could improve treatment for patients with early breast cancer

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus

Treatment of multiple myeloma in Singapore and Asia